首页> 美国卫生研究院文献>Journal of Clinical and Translational Science >2050 Identifying the role and immunobiological mechanisms of Fli-1 mediated pathogenicity in graft Versus host disease
【2h】

2050 Identifying the role and immunobiological mechanisms of Fli-1 mediated pathogenicity in graft Versus host disease

机译:2050年确定Fli-1介导的致病性在移植物抗宿主病中的作用和免疫生物学机制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

OBJECTIVES/SPECIFIC AIMS: Allogeneic hematopoietic stem cell transplantation (allo-HCT) is a curative procedure for hematological malignancies. Chronic graft Versus host disease (cGVHD) is a lethal complication that often develops after allo-HCT. Fli-1 is an aberrantly expressed protein in cancers including erythroleukemia and melanoma, while being implicated in pathogenesis of systemic lupus in mice and humans, a disease with marked similarity to cGVHD. METHODS/STUDY POPULATION: cGVHD was induced using hematopoietic cells from conditional knock-out mice deficient for the fli-1 gene specifically on T cells and progression of cGVHD in murine allo-HCT recipients was monitored using a clinical scoring system, and changes in activation status of hematopoietic cell populations were quantified using flow cytometry. RESULTS/ANTICIPATED RESULTS: Recipients transplanted with fli-1 deficient T cells exhibited reduced cGVHD clinical scores compared with littermate wild-type controls. Donor-grafts containing fli-1 deficient T cells were associated with restrained T-cell responses including reduced Interferon-y cytokine production, PD-1 expression, and differentiation into follicular helper T cells. fli-1 T-cell deficient donor-grafts also improved donor B-cell reconstitution and reduced plasma cells in allo-HCT recipients relative to littermate wild-type control donor-graft recipients. DISCUSSION/SIGNIFICANCE OF IMPACT: Thus, inhibiting Fli-1 represents a promising therapeutic strategy for the goal of preventing cGVHD after allo-HCT while also directly targeting cancers which aberrantly express Fli-1.
机译:目的/特定目的:同种异体造血干细胞移植(allo-HCT)是治疗血液系统恶性肿瘤的一种治疗方法。慢性移植物抗宿主病(cGVHD)是一种致命的并发症,通常在异源HCT后发生。 Fli-1是在包括红白血病和黑色素瘤在内的癌症中异常表达的蛋白质,但与小鼠和人类系统性狼疮的发病机制有关,Fli-1与cGVHD具有明显的相似性。方法/研究人群:使用来自条件性敲除小鼠的fli-1基因缺陷的造血细胞(特异于T细胞)诱导cGVHD,并使用临床评分系统监测小鼠同种HCT受体中cGVHD的进展,使用流式细胞仪定量造血细胞群的状态。结果/预期结果:与同窝野生型对照相比,移植有fli-1缺陷性T细胞的受试者表现出降低的cGVHD临床评分。含有fli-1缺陷型T细胞的供体移植物与受约束的T细胞反应有关,包括减少的干扰素γ细胞因子产生,PD-1表达以及向滤泡性辅助性T细胞的分化。相对于同窝野生型对照供体移植物,fli-1 T细胞缺陷供体移植物还改善了异体HCT受体的供体B细胞重构,并减少了浆细胞。讨论/意义的影响:因此,抑制Fli-1代表了一种有前途的治疗策略,目的是在异基因HCT后预防cGVHD,同时还直接靶向异常表达Fli-1的癌症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号